Related Experiment Video

Updated: Aug 30, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

The paediatric overview

Stuart H Green1

  • 1Neurology Department, Institute of Child Health, University of Birmingham, Whittall Street, B4 6NH, Birmingham, UK. s.h.green@bham.ac.uk

Pediatric Radiology
|December 3, 2003
PubMed

Insights

Pediatric stroke, encompassing ischemic and hemorrhagic types, is a growing concern. Management requires further research due to complex causes and limited adult stroke data applicability.

Area of Science:

  • Pediatric Neurology
  • Vascular Neurology
  • Pediatric Hematology

Background:

  • Stroke in children is an increasingly recognized pediatric illness.
  • Causes are multifactorial, rarely attributable to a single factor.
  • Sickle cell disease and venous sinus thrombosis are significant contributors.

Purpose of the Study:

  • To review the diverse causes of pediatric stroke.
  • To highlight key conditions like sickle cell disease and venous sinus thrombosis.
  • To emphasize the need for further research in pediatric stroke management.

Main Methods:

  • Literature review of pediatric stroke causes and management.
  • Analysis of diagnostic and management strategies.
  • Emphasis on the role of radiology in diagnosis.

Main Results:

  • Pediatric stroke has numerous potential causes, often acting in combination.
  • Sickle cell disease and venous sinus thrombosis are prominent etiological factors.
  • Radiology is essential for diagnosis and guiding management.

Conclusions:

  • Pediatric stroke is a complex condition requiring a comprehensive approach.
  • Management strategies cannot always be extrapolated from adult stroke data.
  • Further clinical trials are essential to define optimal management and understand natural history.

More Related Videos

Adult and Pediatric Porcine Model of Acute Volume Overload06:09

Adult and Pediatric Porcine Model of Acute Volume Overload

Published on: January 12, 2024

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...